Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial

Phytomedicine

Volumn 15, Issue 9, 2008, Pages 668-675

  Bundy, Rafe ^a   Walker, Ann F ^a   Middleton, Richard W ^b   Wallis, Carol ^a   Simpson, Hugh C R ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b Medic Herb UK Ltd   (United Kingdom)

^c ROYAL BERKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Artichoke; Cardiovascular diseases; Cholesterol; Cynara scolymus; Hypercholesterolemia; Phytotherapy

Indexed keywords

CYNARA SCOLYMUS EXTRACT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICHOKE; ARTICLE; BLOATING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FLATULENCE; FORGETFULNESS; HEALTH STATUS; HOT FLUSH; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MEMORY DISORDER; NAUSEA; PLANT LEAF; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WELLBEING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; CHOLESTEROL; CYNARA SCOLYMUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBOS; PLANT EXTRACTS;

CYNARA SCOLYMUS;

EID: 48649100932     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.03.001     Document Type: Article

References (33)

1. Allender S., Peto V., Scarborough P., Boxer A., and Rayner M. Coronary Heart Disease Statistics (2006), British Heart Foundation, London
2. Bowling A. Measuring Health: A Review of Quality of Life Measurement Scales (1997), Open University Press, Buckingham pp. 120-122
3. Bundy R., Walker A.F., Middleton R.W., Marakis G., and Booth J.C. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J. Altern. Complement. Med. 10 (2004) 667-669
4. Casini M.L., Marelli G., Papaleo E., Ferrari A., D'Ambrosio F., and Unfer V. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil. Steril. 85 (2006) 972-978
5. Department of Health. Report on Health and Social Subjects 46. Nutritional Aspects of Cardiovascular Disease (1994), HMSO, London
6. Department of Health. Health Survey for England: Cardiovascular Disease (1998), TSO, London
7. Englisch W., Beckers C., Unkauf M., Ruepp M., and Zinserling V. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 50 (2000) 260-265
8. European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia. fifth ed (2005), Strasbourg, France
9. Fintelmann V., and Menssen H.G. Artichoke leaf extract: current knowledge concerning it efficay as a lipid-reducer and antidyspeptic agent. Dtsch. Apoth. Ztg. 136 (1996) 1405-1414
10. Fintelmann V., and Petrowicz O. Dyspepsia: long-term administration of an artichoke extract for dyspepsia symptoms. Natura Med. 13 (1998) 17-26
11. Food Standards Agency. The Balance of Good Health: Information for Educators and Communicators (2001), FSA, Hayes
12. Food Standards Agency. The National Diet & Nutrition Survey: Adults Aged 19-64 Years. Type and Quantities of Foods Consumed vol. 1 (2002), TSO, London
13. Food Standards Agency, 2004. The National Diet & Nutrition Survey: adults aged 19-64 years. Summary Report Volume 5, TSO, London.
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin. Chem. 18 (1972) 499-502
15. Gebhardt R. Anticholestatic activity of flavonoids from artichoke (Cynara scolymus L.) and of their metabolites. Med. Sci. Monit. 7 Suppl. 1 (2001) 316-320
16. Gebhardt R. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pre-treatment. Phytother. Res. 16 (2002) 368-372
17. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993) 1007-1011
18. Hollis S., and Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319 (1999) 670-674
19. Holtmann G., Adam B., Haag S., Collet W., Grunewald E., and Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment. Pharmacol. Ther. 18 (2003) 1099-1105
20. Kay C.D., Kris-Etherton P.M., and West S.G. Effects of antioxidant-rich foods on vascular reactivity: review of the clinical evidence. Curr. Atheroscler. Rep. 8 (2006) 510-522
21. Kinosian B., Glick H., and Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann. Intern. Med. 121 (1994) 641-647
22. Kraft K. Artichoke leaf extract-recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. Phytomedicine 4 (1997) 369-378
23. Marakis G., Walker A.F., Middleton R.W., Booth J.C., Wright J., and Pike D.J. Artichoke leaf extract reduces mild dyspepsia in an open study. Phytomedicine 9 (2002) 694-699
24. Maron D.J. Flavonoids for reduction of atherosclerotic risk. Curr. Atheroscler. Rep. 6 (2004) 73-78
25. Mills S., and Bone K. Principles and Practice of Phytotherapy (1999), Churchill Livingstone, Edinburgh
26. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
27. Natarajan S., Glick H., Criqui M., Horowitz D., Lipsitz S.R., and Kinosian B. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am. J. Prev. Med. 25 (2003) 50-57
28. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans. sixth ed (2005), US Government Printing Office, Washington, DC
29. Vignes M., Maurice T., Lanté F., Nedjar M., Thethi K., Guiramand J., and Récasens M. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res. 1110 (2006) 102-115
30. Walker A.F., Middleton R.W., and Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytother. Res. 15 (2001) 58-61
31. Wang T.D., Chen W.J., Chien K.L., et al. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am. J. Cardiol. 88 (2001) 737-743
32. Wolffenbuttel B.H., Mahla G., Muller D., Pentrup A., and Black DM. Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia. Neth. J. Med. 52 (1998) 131-137
33. World Health Organization. The World Health Report. Reducing Risks, Promoting Healthy Life (2002), World Health Organization, Geneva